Zimmer Biomet (ZBH) Acquires Monogram Technologies to Expand AI-Driven Orthopedic Robotics Portfolio

Zimmer Biomet Holdings Inc. (NYSE:ZBH) ranks among the best medical device stocks to invest in. Zimmer Biomet Holdings Inc. (NYSE:ZBH) announced on October 7 that it successfully acquired Monogram Technologies Inc., an AI-driven orthopedic robotics firm, for an upfront payment of about $177 million. This expands Zimmer Biomet’s orthopedic solution range by integrating Monogram’s semi-autonomous and fully autonomous robotic technology.

Zimmer Biomet’s technology portfolio already includes its ROSA Robotics platform with almost 2,000 installations globally. According to the company, it is still dedicated to developing the platform, even after the Monogram acquisition. A number of new products, including the ROSA Knee with OptimiZe, which is pending FDA approval, are expected between this year and 2027.

Zimmer Biomet Holdings Inc. (NYSE:ZBH) is a global medical technology company that designs, develops, manufactures, and markets orthopaedic products, including implants, digital and robotic solutions.

While we acknowledge the potential of ZBH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.